healios ltd
healios ltd Company Information
Company Number
08459279
Next Accounts
Sep 2025
Industry
Specialist medical practice activities
Shareholders
inhealth ventures limited
richard andrews
View AllGroup Structure
View All
Contact
Registered Address
vintage house, 36-37 albert embankment, london, SE1 7TL
Website
http://healios.org.ukhealios ltd Estimated Valuation
Pomanda estimates the enterprise value of HEALIOS LTD at £15.4m based on a Turnover of £21.6m and 0.71x industry multiple (adjusted for size and gross margin).
healios ltd Estimated Valuation
Pomanda estimates the enterprise value of HEALIOS LTD at £0 based on an EBITDA of £-11.8m and a 5.52x industry multiple (adjusted for size and gross margin).
healios ltd Estimated Valuation
Pomanda estimates the enterprise value of HEALIOS LTD at £0 based on Net Assets of £-4.4m and 2.29x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Healios Ltd Overview
Healios Ltd is a live company located in london, SE1 7TL with a Companies House number of 08459279. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in March 2013, it's largest shareholder is inhealth ventures limited with a 20.4% stake. Healios Ltd is a established, large sized company, Pomanda has estimated its turnover at £21.6m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Healios Ltd Health Check
Pomanda's financial health check has awarded Healios Ltd a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 7 areas for improvement. Company Health Check FAQs
3 Strong
1 Regular
7 Weak
Size
annual sales of £21.6m, make it larger than the average company (£738.9k)
£21.6m - Healios Ltd
£738.9k - Industry AVG
Growth
3 year (CAGR) sales growth of 58%, show it is growing at a faster rate (7.2%)
58% - Healios Ltd
7.2% - Industry AVG
Production
with a gross margin of 38.5%, this company has a higher cost of product (51.7%)
38.5% - Healios Ltd
51.7% - Industry AVG
Profitability
an operating margin of -54.9% make it less profitable than the average company (12%)
-54.9% - Healios Ltd
12% - Industry AVG
Employees
with 470 employees, this is above the industry average (13)
470 - Healios Ltd
13 - Industry AVG
Pay Structure
on an average salary of £60k, the company has a higher pay structure (£33.4k)
£60k - Healios Ltd
£33.4k - Industry AVG
Efficiency
resulting in sales per employee of £46k, this is less efficient (£82.3k)
£46k - Healios Ltd
£82.3k - Industry AVG
Debtor Days
it gets paid by customers after 30 days, this is near the average (34 days)
30 days - Healios Ltd
34 days - Industry AVG
Creditor Days
its suppliers are paid after 2 days, this is quicker than average (37 days)
2 days - Healios Ltd
37 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Healios Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 18 weeks, this is less cash available to meet short term requirements (57 weeks)
18 weeks - Healios Ltd
57 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 184.7%, this is a higher level of debt than the average (37.4%)
184.7% - Healios Ltd
37.4% - Industry AVG
HEALIOS LTD financials
Healios Ltd's latest turnover from December 2023 is £21.6 million and the company has net assets of -£4.4 million. According to their latest financial statements, Healios Ltd has 470 employees and maintains cash reserves of £2.9 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Mar 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 21,624,078 | 17,935,512 | 10,842,758 | 5,485,327 | 209,280 | 87,885 | |||||
| Other Income Or Grants | 0 | 0 | 0 | 0 | |||||||
| Cost Of Sales | 13,293,585 | 10,745,365 | 6,066,783 | 3,423,245 | |||||||
| Gross Profit | 8,330,493 | 7,190,147 | 4,775,975 | 2,062,082 | |||||||
| Admin Expenses | 20,211,478 | 16,619,872 | 10,558,934 | 4,066,910 | |||||||
| Operating Profit | -11,880,985 | -9,429,725 | -5,782,959 | -2,004,828 | |||||||
| Interest Payable | 1,617,744 | 357,312 | 375 | 7,665 | 8,866 | 1,627 | |||||
| Interest Receivable | 179,888 | 1,408,024 | 0 | 0 | 3 | 5 | |||||
| Pre-Tax Profit | -13,318,841 | -8,379,013 | -5,783,334 | -2,012,493 | -92,983 | 5,924 | |||||
| Tax | 0 | 1,564,346 | 779,515 | 239,273 | 0 | 0 | |||||
| Profit After Tax | -13,318,841 | -6,814,667 | -5,003,819 | -1,773,220 | -92,983 | 5,924 | |||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Retained Profit | -13,318,841 | -6,814,667 | -5,003,819 | -1,773,220 | -92,983 | 5,924 | |||||
| Employee Costs | 28,214,545 | 22,549,098 | 13,498,543 | 223,629 | 87,460 | ||||||
| Number Of Employees | 470 | 424 | 288 | 128 | 55 | 26 | 13 | 8 | |||
| EBITDA* | -11,793,873 | -9,255,938 | -5,598,180 | -1,862,674 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Mar 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 1,882 | 11,268 | 64,852 | 22,028 | 5,597 | 4,468 | 1,876 | 801 | 868 | 335 | 435 |
| Intangible Assets | 1,530 | 80,269 | 191,883 | 316,591 | 437,149 | 601,819 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 3,412 | 91,537 | 256,735 | 338,619 | 442,746 | 606,287 | 1,876 | 801 | 868 | 335 | 435 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 1,832,317 | 3,183,781 | 2,430,183 | 1,861,630 | 370,958 | 95,880 | 66,642 | 55,076 | 2,972 | 13,570 | 14,280 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 482,541 | 2,575,386 | 912,405 | 483,960 | 1,422 | 57,332 | 0 | 0 | 0 | 0 | 0 |
| Cash | 2,857,843 | 10,065,089 | 3,310,499 | 511,978 | 792,226 | 506,816 | 20,518 | 76,608 | 0 | 8,291 | 1,026 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 590 | 0 | 0 |
| total current assets | 5,172,701 | 15,824,256 | 6,653,087 | 2,857,568 | 1,164,606 | 660,028 | 87,160 | 131,684 | 3,562 | 21,861 | 15,306 |
| total assets | 5,176,113 | 15,915,793 | 6,909,822 | 3,196,187 | 1,607,352 | 1,266,315 | 89,036 | 132,485 | 4,430 | 22,196 | 15,741 |
| Bank overdraft | 521,591 | 72,500 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 10,000 | 1,667 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 83,628 | 291,525 | 131,638 | 181,064 | 158,460 | 396,097 | 95,749 | 7,148 | 137,478 | 44,516 | 50,985 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 7,561,427 | 13,760,096 | 6,842,480 | 5,084,003 | 1,800,772 | 234,639 | 332,906 | 234,824 | 0 | 0 | 0 |
| total current liabilities | 8,166,646 | 14,124,121 | 6,984,118 | 5,266,734 | 1,959,232 | 630,736 | 428,655 | 241,972 | 137,478 | 44,516 | 50,985 |
| loans | 1,394,567 | 8,917,982 | 38,333 | 48,333 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19,191 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 1,572,000 | 24,741 | 9,647 | 0 | 0 | 36,936 | 36,936 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7,000 | 7,000 | 0 |
| total long term liabilities | 1,394,567 | 8,917,982 | 38,333 | 48,333 | 1,572,000 | 24,741 | 9,647 | 0 | 26,191 | 43,936 | 36,936 |
| total liabilities | 9,561,213 | 23,042,103 | 7,022,451 | 5,315,067 | 3,531,232 | 655,477 | 438,302 | 241,972 | 163,669 | 88,452 | 87,921 |
| net assets | -4,385,100 | -7,126,310 | -112,629 | -2,118,880 | -1,923,880 | 610,838 | -349,266 | -109,487 | -159,239 | -66,256 | -72,180 |
| total shareholders funds | -4,385,100 | -7,126,310 | -112,629 | -2,118,880 | -1,923,880 | 610,838 | -349,266 | -109,487 | -159,239 | -66,256 | -72,180 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Mar 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||
| Operating Profit | -11,880,985 | -9,429,725 | -5,782,959 | -2,004,828 | |||||||
| Depreciation | 8,373 | 62,173 | 58,821 | 16,446 | 9,494 | 2,185 | 902 | 0 | 300 | 100 | 100 |
| Amortisation | 78,739 | 111,614 | 125,958 | 125,708 | 164,670 | 21,570 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 1,564,346 | 779,515 | 239,273 | 0 | 0 | |||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -3,444,309 | 2,416,579 | 996,998 | 1,973,210 | 219,168 | 86,570 | 11,566 | 52,104 | -10,598 | 13,570 | 14,280 |
| Creditors | -207,897 | 159,887 | -49,426 | 22,604 | -237,637 | 300,348 | 88,601 | -130,330 | 92,962 | 44,516 | 50,985 |
| Accruals and Deferred Income | -6,198,669 | 6,917,616 | 1,758,477 | 3,283,231 | 1,566,133 | -98,267 | 98,082 | 215,633 | 19,191 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7,000 | 0 | 7,000 | 0 |
| Cash flow from operations | -14,756,130 | -3,030,668 | -4,106,612 | -290,776 | |||||||
| Investing Activities | |||||||||||
| capital expenditure | 0 | 0 | 0 | ||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | 0 | 0 | 0 | ||||||||
| Financing Activities | |||||||||||
| Bank loans | 0 | -10,000 | 8,333 | 1,667 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | -7,523,415 | 8,879,649 | -10,000 | 48,333 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | -1,572,000 | 1,547,259 | 15,094 | 9,647 | 0 | -36,936 | 36,936 | 36,936 |
| share issue | |||||||||||
| interest | -1,437,856 | 1,050,712 | -375 | -7,665 | -8,863 | -1,622 | |||||
| cash flow from financing | 7,098,780 | 9,721,347 | 7,008,028 | 48,555 | -45,799 | -36,866 | |||||
| cash and cash equivalents | |||||||||||
| cash | -7,207,246 | 6,754,590 | 2,798,521 | -280,248 | 285,410 | 486,298 | -56,090 | 76,608 | -8,291 | 8,291 | 1,026 |
| overdraft | 449,091 | 72,500 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -7,656,337 | 6,682,090 | 2,798,521 | -280,248 | 285,410 | 486,298 | -56,090 | 76,608 | -8,291 | 8,291 | 1,026 |
healios ltd Credit Report and Business Information
Healios Ltd Competitor Analysis
Perform a competitor analysis for healios ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other large companies, companies in SE1 area or any other competitors across 12 key performance metrics.
healios ltd Ownership
HEALIOS LTD group structure
Healios Ltd has no subsidiary companies.
Ultimate parent company
HEALIOS LTD
08459279
healios ltd directors
Healios Ltd currently has 6 directors. The longest serving directors include Dr Lars Hansen (May 2013) and Ms Maryline Kulawik (Feb 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Lars Hansen | England | 59 years | May 2013 | - | Director |
| Ms Maryline Kulawik | England | 53 years | Feb 2018 | - | Director |
| Mr Richard Bradford | 62 years | Feb 2020 | - | Director | |
| Ms Catriona McDonald | United Kingdom | 31 years | Feb 2021 | - | Director |
| Mr Robbie Allen | England | 54 years | Feb 2023 | - | Director |
| Mr Rob Sarrazin | United States | 54 years | Nov 2023 | - | Director |
P&L
December 2023turnover
21.6m
+21%
operating profit
-11.9m
+26%
gross margin
38.6%
-3.9%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-4.4m
-0.38%
total assets
5.2m
-0.67%
cash
2.9m
-0.72%
net assets
Total assets minus all liabilities
healios ltd company details
company number
08459279
Type
Private limited with Share Capital
industry
86220 - Specialist medical practice activities
incorporation date
March 2013
age
12
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
COOPER PARRY GROUP LIMITED
address
vintage house, 36-37 albert embankment, london, SE1 7TL
Bank
-
Legal Advisor
-
healios ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to healios ltd. Currently there are 1 open charges and 0 have been satisfied in the past.
healios ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for HEALIOS LTD. This can take several minutes, an email will notify you when this has completed.
healios ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
